Soleno Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, with a particular focus on Prader-Willi syndrome. In March 2025, the company secured FDA approval for its first and only treatment targeting hyperphagia in PWS, marking a significant milestone in addressing a critical unmet medical need. Leveraging a rigorous scientific approach alongside strong advocacy and community engagement, Soleno blends cutting-edge research with patient-centric values to deliver impactful solutions. The organization fosters a collaborative culture that empowers scientists, clinicians, and patients to work together toward transformative health outcomes.
Soleno Therapeutics, Inc. is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. We are seeking an experienced and highly motivated individual to manage our contracting process.
Soleno Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, with a particular focus on Prader-Willi syndrome. In March 2025, the company secured FDA approval for its first and only treatment targeting hyperphagia in PWS, marking a significant milestone in addressing a critical unmet medical need. Leveraging a rigorous scientific approach alongside strong advocacy and community engagement, Soleno blends cutting-edge research with patient-centric values to deliver impactful solutions. The organization fosters a collaborative culture that empowers scientists, clinicians, and patients to work together toward transformative health outcomes.
Precision Medicine Group